Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Author Reply.

Brockman JA, Strope SA.

Urology. 2018 Jun;116:130. doi: 10.1016/j.urology.2017.12.044. Epub 2018 Apr 24. No abstract available.

PMID:
29703531
2.

Effect of a Radical Cystectomy Care Pathway on Postoperative Length of Stay and Outcomes.

Brockman JA, Vetter J, Peck V, Strope SA.

Urology. 2018 Jun;116:125-130. doi: 10.1016/j.urology.2017.12.041. Epub 2018 Mar 12.

PMID:
29545042
3.

The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia.

Kim EH, Brockman JA, Andriole GL.

Asian J Urol. 2018 Jan;5(1):28-32. doi: 10.1016/j.ajur.2017.11.005. Epub 2017 Nov 26. Review.

4.

Increased dietary long-chain polyunsaturated fatty acids alter serum fatty acid concentrations and lower risk of urine stone formation in cats.

Hall JA, Brockman JA, Davidson SJ, MacLeay JM, Jewell DE.

PLoS One. 2017 Oct 26;12(10):e0187133. doi: 10.1371/journal.pone.0187133. eCollection 2017.

5.

Prostate MRI: a national survey of Urologist's attitudes and perceptions.

Manley BJ, Brockman JA, Raup VT, Fowler KJ, Andriole GL.

Int Braz J Urol. 2016 May-Jun;42(3):464-71. doi: 10.1590/S1677-5538.IBJU.2015.0235.

6.

The role of the assistant during robot-assisted partial nephrectomy: does experience matter?

Potretzke AM, Knight BA, Brockman JA, Vetter J, Figenshau RS, Bhayani SB, Benway BM.

J Robot Surg. 2016 Jun;10(2):129-34. doi: 10.1007/s11701-016-0582-z. Epub 2016 Apr 2.

PMID:
27039192
7.

Hemorrhagic Cystitis Requiring Bladder Irrigation is Associated with Poor Mortality in Hospitalized Stem Cell Transplant Patients.

Raup VT, Potretzke AM, Manley BJ, Brockman JA, Bhayani SB.

Int Braz J Urol. 2015 Nov-Dec;41(6):1126-31. doi: 10.1590/S1677-5538.IBJU.2014.0655.

8.

The pitfalls of electronic health orders: development of an enhanced institutional protocol after a preventable patient death.

Manley BJ, Gericke RK, Brockman JA, Robles J, Raup VT, Bhayani SB.

Patient Saf Surg. 2014 Sep 27;8(1):39. doi: 10.1186/s13037-014-0039-0. eCollection 2014.

9.

Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy.

Brockman JA, Alanee S, Vickers AJ, Scardino PT, Wood DP, Kibel AS, Lin DW, Bianco FJ Jr, Rabah DM, Klein EA, Ciezki JP, Gao T, Kattan MW, Stephenson AJ.

Eur Urol. 2015 Jun;67(6):1160-1167. doi: 10.1016/j.eururo.2014.09.019. Epub 2014 Oct 6.

10.

Improving the early detection of prostate cancer: a balancing act.

Andriole GL, Brockman JA.

Oncology (Williston Park). 2014 Feb;28(2):142-3. No abstract available.

11.

Shortening medical education.

Duvivier RJ, Stull MJ, Brockman JA.

JAMA. 2012 Jul 11;308(2):133; author reply 136. doi: 10.1001/jama.2012.7022. No abstract available.

PMID:
22782405
12.

Sequencing and comparative genomic analysis of 1227 Felis catus cDNA sequences enriched for developmental, clinical and nutritional phenotypes.

Irizarry KJ, Malladi SB, Gao X, Mitsouras K, Melendez L, Burris PA, Brockman JA, Al-Murrani SW.

BMC Genomics. 2012 Jan 18;13:31. doi: 10.1186/1471-2164-13-31.

13.

The "I want to help people" dilemma: how advocacy training can improve health.

Stull MJ, Brockman JA, Wiley EA.

Acad Med. 2011 Nov;86(11):1349. doi: 10.1097/ACM.0b013e3182308e14. No abstract available.

PMID:
22030648
14.

Dietary fish oil alters the lysophospholipid metabolomic profile and decreases urinary 11-dehydro thromboxane B₂ concentration in healthy Beagles.

Hall JA, Brockman JA, Jewell DE.

Vet Immunol Immunopathol. 2011 Dec 15;144(3-4):355-65. doi: 10.1016/j.vetimm.2011.08.007. Epub 2011 Aug 17.

PMID:
21925741
15.

Do medical professionalism and medical education involve commitments to political advocacy?

Stull MJ, Wiley EA, Brockman JA.

Acad Med. 2011 Sep;86(9):1064; author reply 1065. doi: 10.1097/ACM.0b013e3182267672. No abstract available.

PMID:
21865899
16.

The social mission of medical education.

Brockman JA, Stull MJ, Wiley E.

Ann Intern Med. 2010 Oct 5;153(7):485; author reply 486-7. doi: 10.7326/0003-4819-153-7-201010050-00022. No abstract available.

PMID:
20921556
17.

Light whole genome sequence for SNP discovery across domestic cat breeds.

Mullikin JC, Hansen NF, Shen L, Ebling H, Donahue WF, Tao W, Saranga DJ, Brand A, Rubenfield MJ, Young AC, Cruz P; NISC Comparative Sequencing Program, Driscoll C, David V, Al-Murrani SW, Locniskar MF, Abrahamsen MS, O'Brien SJ, Smith DR, Brockman JA.

BMC Genomics. 2010 Jun 24;11:406. doi: 10.1186/1471-2164-11-406.

18.

Altered expression of hippocampal dentate granule neuron genes in a mouse model of human 22q11 deletion syndrome.

Jurata LW, Gallagher P, Lemire AL, Charles V, Brockman JA, Illingworth EL, Altar CA.

Schizophr Res. 2006 Dec;88(1-3):251-9. Epub 2006 Sep 26.

PMID:
17008057
19.

Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts.

Altar CA, Jurata LW, Charles V, Lemire A, Liu P, Bukhman Y, Young TA, Bullard J, Yokoe H, Webster MJ, Knable MB, Brockman JA.

Biol Psychiatry. 2005 Jul 15;58(2):85-96.

PMID:
16038679
20.

Comparison of microarray-based mRNA profiling technologies for identification of psychiatric disease and drug signatures.

Jurata LW, Bukhman YV, Charles V, Capriglione F, Bullard J, Lemire AL, Mohammed A, Pham Q, Laeng P, Brockman JA, Altar CA.

J Neurosci Methods. 2004 Sep 30;138(1-2):173-88.

PMID:
15325126
21.

Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways.

Altar CA, Laeng P, Jurata LW, Brockman JA, Lemire A, Bullard J, Bukhman YV, Young TA, Charles V, Palfreyman MG.

J Neurosci. 2004 Mar 17;24(11):2667-77.

22.

Novel directions in antipsychotic target identification using gene arrays.

Palfreyman MG, Hook DJ, Klimczak LJ, Brockman JA, Evans DM, Altar CA.

Curr Drug Targets CNS Neurol Disord. 2002 Apr;1(2):227-38. Review.

PMID:
12769629
23.

Peroxisome proliferator-activated receptor gamma-mediated differentiation: a mutation in colon cancer cells reveals divergent and cell type-specific mechanisms.

Gupta RA, Sarraf P, Mueller E, Brockman JA, Prusakiewicz JJ, Eng C, Willson TM, DuBois RN.

J Biol Chem. 2003 Jun 20;278(25):22669-77. Epub 2003 Feb 18.

24.

Peroxisome proliferator-activated receptor gamma and transforming growth factor-beta pathways inhibit intestinal epithelial cell growth by regulating levels of TSC-22.

Gupta RA, Sarraf P, Brockman JA, Shappell SB, Raftery LA, Willson TM, DuBois RN.

J Biol Chem. 2003 Feb 28;278(9):7431-8. Epub 2002 Dec 4.

25.

A cyclooxygenase-2 inhibitor (SC-58125) blocks growth of established human colon cancer xenografts.

Williams CS, Sheng H, Brockman JA, Armandla R, Shao J, Washington MK, Elkahloun AG, DuBois RN.

Neoplasia. 2001 Sep-Oct;3(5):428-36.

26.

The human genome: microarray expression analysis.

Brockman JA, Tamminga CA.

Am J Psychiatry. 2001 Aug;158(8):1199. No abstract available.

PMID:
11481149
27.

Target genes of peroxisome proliferator-activated receptor gamma in colorectal cancer cells.

Gupta RA, Brockman JA, Sarraf P, Willson TM, DuBois RN.

J Biol Chem. 2001 Aug 10;276(32):29681-7. Epub 2001 Jun 7.

28.

Activation of PPARgamma leads to inhibition of anchorage-independent growth of human colorectal cancer cells.

Brockman JA, Gupta RA, Dubois RN.

Gastroenterology. 1998 Nov;115(5):1049-55.

PMID:
9797355
29.

Antioxidant-induced nuclear translocation of CCAAT/enhancer-binding protein beta. A critical role for protein kinase A-mediated phosphorylation of Ser299.

Chinery R, Brockman JA, Dransfield DT, Coffey RJ.

J Biol Chem. 1997 Nov 28;272(48):30356-61. Erratum in: J Biol Chem 1998 Jun 12;273(24):15308.

30.

Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: a p53-independent induction of p21WAF1/CIP1 via C/EBPbeta.

Chinery R, Brockman JA, Peeler MO, Shyr Y, Beauchamp RD, Coffey RJ.

Nat Med. 1997 Nov;3(11):1233-41.

PMID:
9359698
31.

Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor (NF)-kappaB.

Boothby MR, Mora AL, Scherer DC, Brockman JA, Ballard DW.

J Exp Med. 1997 Jun 2;185(11):1897-907.

32.

Corepression of RelA and c-rel inhibits immunoglobulin kappa gene transcription and rearrangement in precursor B lymphocytes.

Scherer DC, Brockman JA, Bendall HH, Zhang GM, Ballard DW, Oltz EM.

Immunity. 1996 Dec;5(6):563-74.

33.

Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.

McKinsey TA, Brockman JA, Scherer DC, Al-Murrani SW, Green PL, Ballard DW.

Mol Cell Biol. 1996 May;16(5):2083-90.

34.

Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination.

Scherer DC, Brockman JA, Chen Z, Maniatis T, Ballard DW.

Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):11259-63.

35.

Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation.

Brockman JA, Scherer DC, McKinsey TA, Hall SM, Qi X, Lee WY, Ballard DW.

Mol Cell Biol. 1995 May;15(5):2809-18.

36.

Transcription of the murine class II Eb gene is regulated primarily at the level of transcriptional initiation.

Egan RM, Brockman JA, Omer KW, Woodward JG.

Cell Immunol. 1994 Jul;156(2):537-43.

PMID:
8025961
37.
38.

Preparation of triazolo[1,5-c]pyrimidines as potential antiasthma agents.

Medwid JB, Paul R, Baker JS, Brockman JA, Du MT, Hallett WA, Hanifin JW, Hardy RA Jr, Tarrant ME, Torley LW, et al.

J Med Chem. 1990 Apr;33(4):1230-41.

PMID:
1969485
39.

Imidazo[1,5-d][1,2,4]triazines as potential antiasthma agents.

Paul R, Brockman JA, Hallett WA, Hanifin JW, Tarrant ME, Torley LW, Callahan FM, Fabio PF, Johnson BD, Lenhard RH, et al.

J Med Chem. 1985 Nov;28(11):1704-16.

PMID:
2415706
40.

Effects of iodipamide on human C3 and factor B in vitro.

Durda PJ, Pagano RJ, Bauman N, Brockman JA.

J Allergy Clin Immunol. 1982 Nov;70(5):353-60.

PMID:
6922882
41.

Lymphokine-induced uptake of [14C]glucosamine, [14C]glucose, and [3H]leucine by macrophages.

Panagides J, Brockman JA, Barg WF.

Inflammation. 1982 Jun;6(2):201-5.

PMID:
7106972
42.

Systematic discovery and evaluation of complement inhibitors.

Bauman N, Brockman JA, Pease BS, Elliott WJ, Colucci DF.

Immunopharmacology. 1981 Dec;3(4):317-24.

PMID:
6460010
43.
44.
45.

Multiple sclerosis: lymphocyte transformation by basic protein from bovine spinal cord.

Brockman JA, Stiffey AV.

Experientia. 1970 Apr 15;26(4):413-4. No abstract available.

PMID:
5439619
46.

An in vitro assay for encephalitogenic components of central nervous tissue.

Brockman JA, Stiffey AV, Tesar WC.

J Immunol. 1968 Jun;100(6):1230-6. No abstract available.

PMID:
5696285
47.

Multiple nature of inhibitory factor (factor I) from brain.

BROCKMAN JA Jr, BURSON SL Jr.

Proc Soc Exp Biol Med. 1957 Mar;94(3):450-2. No abstract available.

PMID:
13408288
48.

Heparin-like anticoagulants from Mollusca.

FROMMHAGEN LH, FAHRENBACH MJ, BROCKMAN JA Jr, STOKSTAD EL.

Proc Soc Exp Biol Med. 1953 Feb;82(2):280-3. No abstract available.

PMID:
13037871
49.

Comparative biological activity of leucovorin and pteroylglutamic acid.

BROQUIST HP, BROCKMAN JA Jr, FAHRENBACH MJ, STOKSTAD EL, JUKES TH.

J Nutr. 1952 May;47(1):93-103. No abstract available.

PMID:
14939085
50.

Alkaloids of Dichroa febrifuga; isolation and degradative studies.

KOEPFLI JB, MEAD JF, BROCKMAN JA Jr.

J Am Chem Soc. 1949 Mar;71(3):1048-54. No abstract available.

PMID:
18124517

Supplemental Content

Loading ...
Support Center